Table 1:
Demographics and baseline data
| All patients (n = 58) | Survivors (n = 51) | Non-survivors (n = 7) | P | |
|---|---|---|---|---|
| Sex (male) | 69% (40) | 70.6% (36) | 57.1% (4) | 0.66 |
| Age (years) | 64.9 ± 11.6 | 64.6 ± 9.6 | 66.9 ± 10.3 | 0.92 |
| Body mass index (kg m−2) | 27 ± 4.2 | 27.6 ± 4.6 | 26.6 ± 4.2 | 0.54 |
| Hypertension | 56.9% (33) | 54.9% (28) | 71.4% (5) | 0.68 |
| Diabetes mellitus | 32.8% (19) | 33.3% (17) | 28.6% (2) | 0.99 |
| Dyslipidaemia | 34.5% (20) | 33.3% (17) | 42.9% (3) | 0.68 |
| Chronic renal insufficiency | 8.6% (5) | 7.8% (4) | 14.3% (1) | 0.12 |
| Renal failure (on dialysis) | 19% (11) | 19.60% (10) | 14.3% (1) | 0.60 |
| Creatinine before surgery (mmol l−1) | 114.4 ± 100.8 | 106.4 ± 93.7 | 170.3 ± 136.3 | 0.15 |
| Previous stroke | 12.1% (7) | 12.1% (7) | 0% | 0.23 |
| Chronic obstructive pulmonary disease | 17.2% (10) | 17.6% (9) | 14.3% (1) | 0.85 |
| Active smokers | 19% (11) | 19.6% (10) | 14.3% (1) | 0.64 |
| Active alcohol consumption | 3.4% (2) | 3.9% (2) | 0% | 0.84 |
| Previous atrial fibrillation | 31% (18) | 33.3% (17) | 14.3% (1) | 0.78 |
| Previous myocardial infarction | 12.1% (7) | 11.8% (6) | 14.3% (1) | 0.53 |
| NYHA class III-IV | 34.5% (20) | 35.3% (18) | 28.6% (2) | 0.58 |
| On B-blockers | 39.7% (23) | 41.2% (21) | 28.6% (2) | 0.69 |
| On statins | 25.9% (15) | 25.50% (13) | 28.6% (2) | 0.92 |
| Ascites (moderate to severe) | 69% (40) | 70.6% (36) | 57.1% (4) | 0.45 |
| Oesophageal varices | 31% (18) | 25.5% (13) | 71.4% (5) | 0.26 |
| Variceal bleeding | 17.2% (10) | 17.6% (9) | 14.3% (1) | 0.14 |
| Encephalopathy | 34.5% (20) | 33.3%(17) | 42.9% (3) | 0.32 |
| Hypertrophic cardiomyopathy | 31% (18) | 31.4% (16) | 28.6% (2) | 0.68 |
| Dilated cardiomyopathy | 27.6% (16) | 27.5% (14) | 28.6% (2) | 0.91 |
| Left ventricular ejection fraction (%) | 60.3 ± 11.2 | 59.3 ± 11.7 | 62.6 ± 10.1 | 0.71 |
| Pulmonary arterial pressure (mmHg) | 48.7 ± 15.4 | 48.6 ± 15.6 | 49.4 ± 14.7 | 0.58 |
| Haemoglobin before surgery (g dl−1) | 11.67 ± 1.82 | 11.8 ± 1.8 | 10.2 ± 1.05 | 0.02 |
| Platelet count before surgery (1 nl−1) | 164 ± 85 | 171 ± 87 | 113 ± 52 | 0.03 |
| International normalized ratio before surgery | 1.5 ± 0.83 | 1.45 ± 0.15 | 1.85 ± 0.76 | 0.18 |
NYHA: New York Heart Association classification. Results are expressed as mean ± standard deviation or percentage.